Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,037,966
+$3,275,245 QoQ
Shares Held
86,066
+0.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Advisory Services Network, LLC holds $159,480,021 across 17 Drug Manufacturers - General names. JNJ ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,669 | $46,603,818 | |
| 2 | ABBV |
AbbVie Inc.
|
118,301 | $25,729,278 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
86,066 | $21,037,966 | |
| 4 | MRK |
Merck & Co., Inc.
|
143,304 | $17,238,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
74,137 | $10,332,465 | |
| 6 | AMGN |
Amgen Inc
|
29,101 | $10,239,178 | |
| 7 | PFE |
Pfizer Inc
|
258,469 | $7,257,803 | |
| 8 | NVS |
Novartis AG
|
38,689 | $5,909,741 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,037,966 | 86,066 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,762,721 | 85,831 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $15,619,589 | 84,239 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $13,111,750 | 85,838 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $12,073,144 | 72,800 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,289,609 | 78,064 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $13,056,523 | 80,566 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,775,522 | 80,566 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $13,804,131 | 87,263 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $13,780,892 | 87,922 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $16,411,219 | 105,369 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,027,514 | 114,956 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $18,682,925 | 120,535 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $20,014,619 | 113,301 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $18,334,053 | 112,231 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $19,372,195 | 109,133 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $17,288,960 | 97,551 | Shares | Sole | 2022-05-23 | |
| 2021-12-31 | $15,777,098 | 92,226 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $13,549,849 | 83,900 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $11,933,597 | 72,439 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $11,458,478 | 69,720 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $9,197,284 | 58,440 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $7,727,017 | 51,901 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,911,399 | 49,146 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $5,831,741 | 44,473 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||